JP2016519595A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519595A5
JP2016519595A5 JP2016503336A JP2016503336A JP2016519595A5 JP 2016519595 A5 JP2016519595 A5 JP 2016519595A5 JP 2016503336 A JP2016503336 A JP 2016503336A JP 2016503336 A JP2016503336 A JP 2016503336A JP 2016519595 A5 JP2016519595 A5 JP 2016519595A5
Authority
JP
Japan
Prior art keywords
treatment
brain activity
baseline
therapy
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016503336A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519595A (ja
JP6585030B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/030138 external-priority patent/WO2014145382A2/en
Publication of JP2016519595A publication Critical patent/JP2016519595A/ja
Publication of JP2016519595A5 publication Critical patent/JP2016519595A5/ja
Application granted granted Critical
Publication of JP6585030B2 publication Critical patent/JP6585030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016503336A 2013-03-15 2014-03-17 自閉症スペクトラム障害におけるgaba−bアゴニスト薬物活性の脳磁図バイオマーカー Active JP6585030B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361787077P 2013-03-15 2013-03-15
US61/787,077 2013-03-15
PCT/US2014/030138 WO2014145382A2 (en) 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders

Publications (3)

Publication Number Publication Date
JP2016519595A JP2016519595A (ja) 2016-07-07
JP2016519595A5 true JP2016519595A5 (https=) 2017-04-27
JP6585030B2 JP6585030B2 (ja) 2019-10-02

Family

ID=51538466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016503336A Active JP6585030B2 (ja) 2013-03-15 2014-03-17 自閉症スペクトラム障害におけるgaba−bアゴニスト薬物活性の脳磁図バイオマーカー

Country Status (6)

Country Link
US (1) US10342480B2 (https=)
EP (1) EP2967405A4 (https=)
JP (1) JP6585030B2 (https=)
AU (1) AU2014233048B2 (https=)
CA (1) CA2907494C (https=)
WO (1) WO2014145382A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018194959A1 (en) * 2017-04-17 2018-10-25 Miron Oren Auditory brainstem response for autism prediction
WO2019060298A1 (en) 2017-09-19 2019-03-28 Neuroenhancement Lab, LLC METHOD AND APPARATUS FOR NEURO-ACTIVATION
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11426073B2 (en) * 2018-04-27 2022-08-30 Washington University Imaging nerve function and pathologies using diffusion basis spectrum imaging
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
FI20185893A1 (fi) * 2018-10-23 2020-04-24 Elekta Oy Päähän asennettava laitteisto
JP2022505676A (ja) * 2018-10-23 2022-01-14 ブラックソーン セラピューティクス インコーポレイテッド 患者のスクリーニング、診断、及び層別化のためのシステム及び方法
WO2020186148A1 (en) 2019-03-13 2020-09-17 The Children's Hospital Of Philadelphia Methods for the detection of brain injury
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
WO2021096946A1 (en) * 2019-11-15 2021-05-20 The University Of Chicago Cancer detection based on four quadrant mapping and matrix analysis of image data
US12521053B2 (en) * 2022-01-05 2026-01-13 Tdk Corporation Methods and devices for electromagnetic measurements from ear cavity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2540295A1 (en) * 2011-06-27 2013-01-02 Centre national de la recherche scientifique Compositions for the treatment of Fragile X syndrome

Similar Documents

Publication Publication Date Title
JP2016519595A5 (https=)
IL304429A (en) Methods and compositions for treatment of epileptic disorders
Simons et al. Psychological processing in chronic pain: a neural systems approach
IL290455A (en) Methods of treating psychological and brain disorders
HUE055334T2 (hu) Szerves vegyületek és azok alkalmazása központi idegrendszeri betegségek kezelésében vagy megelõzésében
EP3720553C0 (en) PHOTOBIOMODULATION DEVICE FOR THE TREATMENT OF A RETINAL DISEASE
IL287032A (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
HUE049237T2 (hu) Készítmények a bõr sérülései, rendellenességei és betegségei kezelési eljárásaiban történõ alkalmazásra
WO2016070051A3 (en) Combination therapy for treatment of disease
IL246579B (en) Compounds that inhibit the activity of 2lrrk and their use in the treatment of Parkinson's disease
EP3429605A4 (en) THERAPEUTIC FOR THE TREATMENT OF DISEASES INCLUDING THE CENTRAL NERVOUS SYSTEM
GEP20217253B (en) ANTIBODIES TO α-SYNUCLEIN AND USES THEREOF
PT3405215T (pt) Métodos para o tratamento da doença de danon e outros transtornos da autofagia
EP3490436A4 (en) METHOD FOR DETECTING AND TREATING PAIN USING BRAIN ACTIVITY
WO2016097315A3 (en) Blood brain barrier transport molecules and uses thereof
BR112017018964A2 (pt) uso de plinabulin e métodos para tratar tumor cerebral
IL269083A (en) Methods for preventing and treating heart disease
EP3581175A4 (en) PREPARATION FOR THE ADMINISTRATION OF A DRUG FOR THE TREATMENT OF MENTAL ILLNESSES OR CENTRAL NERVOUS SYSTEM DISORDERS
WO2017040666A3 (en) Combination therapy for treatment of disease
IL275322A (en) Bispecific molecules that bind 16-CD and their therapeutic use
EP3517160A4 (en) DEVICE, METHOD AND PROGRAM FOR MEMORY TRAINING BY BRAIN STIMULATION
EP4488288A3 (en) Means and methods for aav gene therapy in humans
WO2017143115A3 (en) Enhancing the therapeutic activity of an immune checkpoint inhibitor
Roiser What has neuroscience ever done for us?
SG11202100235YA (en) Prevention or treatment method for peripheral neuropathy or pain accompanying disease in which peripheral neuropathy or astrocyte disorder is recognized